Leadless pacemaker implantation in a patient with a fully magnetically levitated left ventricular assist device.

Publisher: Futura Pub. Co. Country of Publication: United States NLM ID: 7803944 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-8159 (Electronic) Linking ISSN: 01478389 NLM ISO Abbreviation: Pacing Clin Electrophysiol Subsets: MEDLINE

Original Publication: Mount Kisco, N. Y. : Futura Pub. Co., c1978-

Heart-Assist Devices* ; Pacemaker, Artificial*; Heart Failure/*therapy ; Sarcoidosis/*therapy; Aged ; Electrocardiography ; Epicardial Mapping ; Female ; Fluoroscopy ; Heart Failure/physiopathology ; Humans ; Prosthesis Design ; Sarcoidosis/physiopathology

Left ventricular assist device (LVAD) therapy is increasingly used in patients with end-stage heart failure. However, LVADs are associated with challenges, especially in the presence of a cardiac implantable electronic device. Although a leadless pacemaker (PM), the Micra™ Transcatheter Pacing System, can be used with LVADs, data regarding HeartMate 3™ LVAD are limited. In this report, we present a patient with a HeartMate 3™ LVAD who underwent successful leadless PM implantation after the removal of an infected cardiac resynchronization therapy defibrillator.
(© 2021 Wiley Periodicals LLC.)

Berg DD, Vaduganathan M, Upadhyay GA, Singh JP, Mehra MR, Stewart GC. Cardiac implantable electronic devices in patients with left ventricular assist systems. J Am Coll Cardiol. 2018;71:1483-1493.
Kormos RL, Cowger J, Pagani FD, et al. The society of thoracic surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019;38:114-126.
El-Chami MF, Soejima K, Piccini JP, et al. Incidence and outcome of systemic infections in patients with leadless pacemakers: data from the micra IDE study. Pacing Clin Electrophysiol. 2019;42:1105-1110.
Reynolds D, Duray GZ, Omar R, et al. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2016;374:533-541.
Cave, MH, Wallwork, J, Schofield, PM. Permanent pacing in a patient with a left ventricular assist system. Heart. 1996;75:525-527.
Collart, F, Dieuzaide, P, Kerbaul, F, Mouly-Bandini, A, Mesana, TG. Complete atrioventricular block decreases left ventricular assist device flow rate. Ann Thorac Surg. 2005;80:716-717.
Elkaryoni, A, Badarin, FA, Khan, MS, et al. Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous flow left ventricular assist devices: a systematic review and meta-analysis. Europace 2019;21:1353-1359.
Gopinathannair, R., Roukoz, H., Bhan, A., et al. Cardiac resynchronization therapy and clinical outcomes in continuous flow left ventricular assist device recipients. J Am Heart Assoc. 2018;7:e009091.
El-Chami, MF, Bonner, M, Holbrook, R, et al. Leadless pacemakers reduce risk of device-related infection: review of the potential mechanisms. Heart Rhythm 2020;17:1393-1397.
Parker, AM, Vilaro, JR, Aranda, JM Jr, Al-Ani, M., George, P Jr, Ahmed, MM. Leadless pacemaker use in a patient with a durable left ventricular assist device. Pacing Clin Electrophysiol 2020;43:1048-1050.
Sehatbakhsh, S, Kushnir, A, Kabach, M, Kolek, M, Chait, R, Ghumman, W. A case of electromagnetic interference between HeartMate 3 LVAD and implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2018;41:218-220.
Meineri, M, Van Rensburg, A, Vegas, A. Right ventricular failure after LVAD implantation: prevention and treatment. Best Pract Res Clin Anaesthesiol. 2012;26:217-229.
Takasugi, N, Kubota, T, Kawamura, I et al. Sudden reversible pacemaker failure in a patient with cardiac sarcoidosis: an unfortunate case of ventricular septal pacing. Europace 2012;14:1061-1062.

Keywords: HeartMate 3(; Leadless pacemaker; Micra Transcatheter Pacing System; electromagnetic interference; left ventricular assist device

Date Created: 20210201 Date Completed: 20220126 Latest Revision: 20220126

20231215

10.1111/pace.14182

33521993